Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TFR1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TFR1 is a gene implicated in neurodegeneration research. Key relationships include: activates, therapeutic target, regulates. Associated with ALS, Aging, Als. Connected to 277 entities in the SciDEX knowledge graph.
| Gene Symbol | TFR1 |
| Full Name | Transferrin Receptor 1 |
| Chromosome | 3q29 |
| Protein Type | Receptor |
| Target Class | Receptor |
| Function | Monoclonal antibodies targeting receptor or iron chelation affecting iron uptake |
| Mechanism of Action | Monoclonal antibodies targeting receptor or iron chelation affecting iron uptake |
| Primary Expression | Ubiquitous, highest in proliferating cells and erythroid precursors |
| Druggability | Low (0.44) |
| Clinical Stage | Approved |
| Pathways | Amyloid, Complement, Endocytosis, Oxidative Stress, Phagocytosis |
| UniProt ID | P02786 |
| NCBI Gene ID | 7037 |
| Ensembl ID | ENSG00000149571 |
| GeneCards | TFR1 |
| Human Protein Atlas | TFR1 |
| Associated Diseases | ALS, Alzheimer, CANCER, Dementia, Ischemia |
| Known Drugs/Compounds | iron-transferrin complex, paricalcitol, valproic acid |
| Interactions | LRP1, CAV1, ABCB1, GBA1, LC3, FTH1 |
| SciDEX Target | View Target Profile (8 clinical trials) |
| SciDEX Hypotheses | Magnetosonic-Triggered Transferrin Receptor Cluste |
| KG Connections | 538 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
TFR1["TFR1"] -->|"associated"| neurodegeneration["neurodegeneration"]
TFR1["TFR1"] -->|"interacts"| LRP1["LRP1"]
TFR1["TFR1"] -->|"interacts"| CAV1["CAV1"]
TFR1["TFR1"] -->|"interacts"| ABCB1["ABCB1"]
TFR1["TFR1"] -->|"co discussed"| AQP4["AQP4"]
TFR1["TFR1"] -->|"co discussed"| CAV1_1["CAV1"]
LRP1_2["LRP1"] -->|"interacts"| TFR1["TFR1"]
CAV1_3["CAV1"] -->|"interacts"| TFR1["TFR1"]
ABCB1_4["ABCB1"] -->|"interacts"| TFR1["TFR1"]
LRP1_5["LRP1"] -->|"co discussed"| TFR1["TFR1"]
style TFR1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| iron uptake | mediates | process | 0.95 |
| iron-transferrin complex | binds | compound | 0.95 |
| Ferroptosis | activates | pathway | 0.90 |
| Ferroptosis | involved_in | process | 0.88 |
| tumorigenesis | involved_in | process | 0.85 |
| cancer progression | promotes | process | 0.85 |
| Ferroptosis | mediates | process | 0.85 |
| transferrin_receptor | encodes | protein | 0.80 |
| Parkinson | activates | disease | 0.75 |
| Tumor | therapeutic_target | disease | 0.75 |
| Neurodegeneration | activates | disease | 0.75 |
| Aging | activates | disease | 0.75 |
| Autophagy | activates | pathway | 0.70 |
| Ferroptosis | biomarker_for | pathway | 0.70 |
| Alzheimer's Disease | involved_in | disease | 0.70 |
| Ischemia | regulates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Cancer | biomarker_for | disease | 0.65 |
| Lymphoma | biomarker_for | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Dementia | contributes_to | disease | 0.65 |
| Als | contributes_to | disease | 0.65 |
| Ischemia | contributes_to | disease | 0.65 |
| Alzheimer | contributes_to | disease | 0.65 |
| Ms | contributes_to | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Cardiac | therapeutic_target | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Senescence | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Depression | inhibits | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Synucleinopathy | activates | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Ischemia | associated_with | disease | 0.65 |
| Osteoporosis | therapeutic_target | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GPX4 | co_mentioned_with | gene | 0.90 |
| h-84808267 | targets_gene | hypothesis | 0.90 |
| h-aa2d317c | targets_gene | hypothesis | 0.90 |
| FERROPTOSIS | activates | gene | 0.90 |
| h-84808267 | targets | hypothesis | 0.80 |
| h-aa2d317c | targets | hypothesis | 0.80 |
| GPX4 | activates | gene | 0.80 |
| SLC7A11 | activates | gene | 0.70 |
| PARKINSON'S DISEASE | activates | gene | 0.70 |
| LRP1 | interacts_with | gene | 0.65 |
| CAV1 | interacts_with | gene | 0.65 |
| ABCB1 | interacts_with | gene | 0.65 |
| ACSL4 | co_mentioned_with | gene | 0.60 |
| SLC7A11 | co_mentioned_with | gene | 0.60 |
| JUN | regulates | gene | 0.60 |
| JUN | interacts_with | gene | 0.60 |
| JUN | therapeutic_target | gene | 0.60 |
| PINK1 | therapeutic_target | gene | 0.60 |
| PTEN | therapeutic_target | gene | 0.60 |
| KEAP1 | associated_with | gene | 0.60 |
| HFE | regulates | gene | 0.60 |
| DMT1 | associated_with | gene | 0.60 |
| GPX4 | contributes_to | gene | 0.60 |
| ACSL4 | expressed_in | gene | 0.60 |
| GPX4 | associated_with | gene | 0.60 |
| GBA1 | activates | gene | 0.60 |
| CD44 | activates | gene | 0.60 |
| LOX | inhibits | gene | 0.60 |
| ACSL4 | inhibits | gene | 0.60 |
| XPC | regulates | gene | 0.60 |
| SRC | therapeutic_target | gene | 0.60 |
| GOT1 | activates | gene | 0.60 |
| ACSL4 | activates | gene | 0.60 |
| CAT | associated_with | gene | 0.60 |
| FERROPORTIN | transports | gene | 0.60 |
| TFRC | expressed_in | gene | 0.60 |
| LC3 | activates | gene | 0.60 |
| IREB2 | activates | gene | 0.60 |
| TP53 | activates | gene | 0.60 |
| ALOX12 | activates | gene | 0.60 |
| BECN1 | activates | gene | 0.60 |
| SLC7A11 | expressed_in | gene | 0.60 |
| FTH1 | expressed_in | gene | 0.60 |
| GPX4 | expressed_in | gene | 0.60 |
| NRF2 | expressed_in | gene | 0.60 |
| APP | treats | gene | 0.60 |
| FTL | expressed_in | gene | 0.60 |
| FSP1 | therapeutic_target | gene | 0.60 |
| TAU | therapeutic_target | gene | 0.60 |
| BECLIN1 | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Magnetosonic-Triggered Transferrin Receptor Clustering | 0.470 | neurodegeneration | Blood-brain barrier transport mechanisms |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.566
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease. [PMID:40425446] | Sehlin D, Hultqvist G, Michno W, Aguilar | J Prev Alzheimers Dis | 2025 | 1 |
| Effect of ferroptosis on chronic cerebral hypoperfusion in vascular dementia. [PMID:37709116] | Fu P, Chen Y, Wu M, Bao B, Yin X, Chen Z | Exp Neurol | 2023 | 1 |
| On Iron Metabolism and Its Regulation. [PMID:33925597] | Vogt AS, Arsiwala T, Mohsen M, Vogel M, | Int J Mol Sci | 2021 | 1 |
| Transferrin Receptor Is a Specific Ferroptosis Marker. [PMID:32160546] | Feng H, Schorpp K, Jin J, Yozwiak CE, Ho | Cell Rep | 2020 | 1 |
| Transferrin and transferrin receptors update. [PMID:29969719] | Kawabata H | Free Radic Biol Med | 2019 | 1 |
| A proimmunotoxin nanodrug targeting AIDS-associated non-Hodgkin lymphoma. [PMID:41592623] | Chen S, Qi T, Peng H, Kimura E, Zhang X | J Control Release | 2026 | 0 |
| Time- and dose-dependent effects of bacterial infection on iron metabolism, infl [PMID:41619877] | Lu Y, Zhang Y, Niu C | Comp Biochem Physiol A Mol Int | 2026 | 0 |
| Ayanin combats against barium sulphate nanoparticles induced hepatotoxicity via [PMID:41666660] | Zhu D, Lu Y, Jamil S, Ashfaq H, Al-Emam | J Trace Elem Med Biol | 2026 | 0 |
| Role of iron and TfR1 in the application of high‑dose ascorbate against pancreat [PMID:41789665] | Piotrowsky A, Leischner C, Schmieder H, | Oncol Rep | 2026 | 0 |
| Brain and Liver Dual-Targeting Oridonin Nanoparticles to Enhance Aβ Clearance fo [PMID:41944296] | Gong W, Hui W, Qiao S, Ji Q, Liu M et al | Adv Sci (Weinh) | 2026 | 0 |
| Cerebrospinal Fluid from Restless Legs Syndrome Patients Reduces Iron Uptake in [PMID:41947413] | Palsa K, Sahu AP, Rye DB, Trotti LM, Elc | Ann Neurol | 2026 | 0 |
| Pulmonary neuroendocrine cell-derived exosomes regulate iron homeostasis and oxi [PMID:41950316] | Thakur A, Zhang K, Chen J, Mei S, Chen J | Sci Adv | 2026 | 0 |
| O-GlcNAc Modification Orchestrates HUWE1-Mediated Ubiquitination of TfR1 to Regu [PMID:41962599] | Zhang H, Li M, Zhang J, Sun Q, Jin X et | Free Radic Biol Med | 2026 | 0 |
| Protective Role of Polydatin Against Vancomycin-Induced Lung Toxicity via Oxidat [PMID:41963266] | Aygörmez S, Küçükler S, Çomaklı S, Şimşe | J Appl Toxicol | 2026 | 0 |
| Yangxin granules exert cardioprotective effects against acute myocardial infarct [PMID:41868900] | Huo G, Zhou Y, Wu Z, Sun S, Zhu G, Cheng | American journal of translatio | 2026 | 0 |
| Conformational dynamics study of TfR1 upon transferrin binding via NMA and MD si [PMID:41921418] | Zemmouche M, Falque G, Cadet F, Gardebie | Journal of molecular graphics | 2026 | 0 |
| [Effects of acupuncture on ferroptosis and ferritinophagy in cerebral ischemia-r [PMID:41839581] | Wang YF, Dong YS | Zhen ci yan jiu = Acupuncture | 2026 | 0 |
| The therapeutic potential of Piezo1 channel-mediated ferroptosis and its inhibit [PMID:41854751] | Nan K, Zhang L, Zhao Y, Yin S, Peng Y, H | Apoptosis : an international j | 2026 | 0 |
| The Role of Artemisinin and its Derivatives in Cancer Therapy via Ferroptosis: A [PMID:41833023] | Osmanlioglu Dag SR, Tatli Cankaya II, Oz | Anti-cancer agents in medicina | 2026 | 0 |
| Raccoon eyes. [PMID:35789012] | Ning J | Journal of paediatrics and chi | 2023 | 0 |